PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 93 filers reported holding PMV PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $376,950 | -1.8% | 61,394 | +0.1% | 0.00% | – |
| Q2 2023 | $383,825 | +138465.0% | 61,314 | +5.7% | 0.00% | – |
| Q1 2023 | $277 | -43.6% | 57,998 | +2.8% | 0.00% | -100.0% |
| Q4 2022 | $491 | -99.9% | 56,414 | +1.4% | 0.00% | 0.0% |
| Q3 2022 | $662,000 | -12.1% | 55,659 | +5.4% | 0.00% | 0.0% |
| Q2 2022 | $753,000 | +30.5% | 52,821 | +90.8% | 0.00% | 0.0% |
| Q1 2022 | $577,000 | -2.9% | 27,690 | +7.7% | 0.00% | 0.0% |
| Q4 2021 | $594,000 | -19.6% | 25,707 | +3.6% | 0.00% | 0.0% |
| Q3 2021 | $739,000 | -8.2% | 24,811 | +5.3% | 0.00% | 0.0% |
| Q2 2021 | $805,000 | +74.6% | 23,554 | +68.0% | 0.00% | 0.0% |
| Q1 2021 | $461,000 | -46.2% | 14,018 | +0.6% | 0.00% | 0.0% |
| Q4 2020 | $857,000 | – | 13,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |